The healthcare future for thousands of low-income women in Texas is uncertain as the federal government phases out its Medicaid funding for the Texas Women’s Health Program over the next three to six months.

A lawsuit in which Texas accused Johnson & Johnson of plundering the state Medicaid program by overstating the safety of an expensive anti-psychotic drug and improperly influencing officials and doctors has been settled for $158 million.